What is the clinical evidence from this study?

Study design: Review. Population: Heart failure. Intervention: Cardiac natriuretic peptides (ANP, BNP, CNP).

What question did this study set out to answer?

To review the molecular regulation, biological actions, and clinical translation of cardiac natriuretic peptides as diagnostic markers and therapeutic agents in heart failure.

April 23, 2010Cardiovascular TherapeuticsOpen Access

Cardiac Natriuretic Peptides: From Basic Discovery to Clinical Practice

View Full Paper

Ask AI

Bookmark

Key result

Cardiac natriuretic peptides serve as highly effective quantitative biomarkers for heart failure diagnosis and risk-stratification, while synthetic forms offer therapeutic potential.

Design

Review

Authors

SHSalim S. HayekCross-Cutting Cardiology MNMona NemerPediatric / Congenital Cardiology

Discussion

Member takes

Implication

Supports current HF biomarker strategies; leaves open definitive therapeutic roles for synthetic peptides pending trials.

Key Points

To review the molecular regulation, biological actions, and clinical translation of cardiac natriuretic peptides as diagnostic markers and therapeutic agents in heart failure.
Synthesized molecular findings on ANP and BNP gene promoters and upstream transcriptional regulators, including GATA4, TBX5, and NKX2-5.
Assessed clinical evidence regarding plasma natriuretic peptides for heart failure diagnosis and synthetic peptide therapeutics, including anaritide and nesiritide.
Transcription factors GATA4, TBX5, and NKX2-5 directly regulate ANP and BNP expression during early myocyte differentiation and under cardiac stress.
Plasma natriuretic peptide concentrations serve as quantitative clinical biomarkers for diagnosing heart failure, guiding targeted medical therapy, and screening subclinical cardiac stress.
Synthetic peptide therapies demonstrate documented clinical benefits and risks in the therapeutic management of heart failure, hypertension, and renal failure.

PICO

Population

Heart failure

Intervention / Comparator

Cardiac natriuretic peptides (ANP, BNP, CNP)

This review highlights the critical role of cardiac natriuretic peptides as diagnostic biomarkers and potential therapeutic targets in heart failure.

Cite This Study

Hayek et al. (2010) conducted a review in Heart failure. Cardiac natriuretic peptides (ANP, BNP, CNP) was evaluated. Cardiac natriuretic peptides serve as highly effective quantitative biomarkers for heart failure diagnosis and risk-stratification, while synthetic forms offer therapeutic potential.

synapsesocial.com/papers/6a17501c5c24d7ef898d8769 https://doi.org/10.1111/j.1755-5922.2010.00152.x

View Full Paper

Ask AI

Bookmark

Cardiac Natriuretic Peptides: From Basic Discovery to Clinical Practice

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Cardiac Natriuretic Peptides: From Basic Discovery to Clinical Practice

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Also Consider